Aetna November 2017 Medical Policy Updates

Post Views: 944

Click here to view the Aetna Medical Policy Updates »

November 2017

New:

November 10, 2017 – 0920 – Tisagenlecleucel (Kymriah)
November 3, 2017 – 0919 – Inotuzumab Ozogamicin (Besponsa)

Revised:

November 3, 2017 – 0753 – Core Decompression for Avascular Necrosis
November 3, 2017 – 0759 – Vulvodynia and Vulvar Vestibulitis Treatments
November 3, 2017 – 0761 – Certolizumab Pegol (Cimzia)
November 3, 2017 – 0762 – Repository Corticotropin Injection (H.P. Acthar Gel)
November 3, 2017 – 0763 – Homocysteine Testing
November 3, 2017 – 0766 – High Intensity Focused Ultrasound
November 3, 2017 – 0769 – Endometrial Cancer Screening and Diagnosis
November 3, 2017 – 0770 – Rilonacept (Arcalyst)
November 3, 2017 – 0771 – Procalcitonin (PCT)
November 3, 2017 – 0774 – Nerve Fiber Density Measurement
November 3, 2017 – 0779 – Plerixafor (Mozobil) Injection
November 3, 2017 – 0780 – ADAMTS13 Assay for Thrombotic Thrombocytopenic Purpura (TTP)
November 3, 2017 – 0781 – Interstitial Laser Therapy
November 3, 2017 – 0783 – In Vivo Analysis of Gastro-Intestinal and Urothelial Lesions
November 3, 2017 – 0784 – Blood Product Injections for Selected Indications
November 3, 2017 – 0785 – Peripheral Vascular Stents
November 2, 2017 – 0287 – Total Hip Replacement
November 2, 2017 – 0398 – Idiopathic Scoliosis
November 2, 2017 – 0501 – Gonadotropin-Releasing Hormone Analogs and Antagonists
November 2, 2017 – 0717 – Analysis of Volatile Organic Compounds
November 2, 2017 – 0719 – Fluocinolone Acetonide Intra-vitreal Implant (Retisert and Iluvien)
November 2, 2017 – 0720 – Abatacept (Orencia)
November 2, 2017 – 0724 – Antiemetic Injection Therapy
November 2, 2017 – 0725 – Post-Herpetic Neuralgia
November 2, 2017 – 0728 – Barrett’s Esophagus
November 2, 2017 – 0729 – Diabetic Neuropathy: Selected Treatments
November 2, 2017 – 0732 – Guillain-Barre Syndrome Treatments
November 2, 2017 – 0734 – External Ocular Photography
November 2, 2017 – 0735 – Pulsed Radiofrequency
November 2, 2017 – 0737 – Double Balloon Enteroscopy
November 2, 2017 – 0738 – Upper Gastrointestinal Endoscopy
November 2, 2017 – 0739 – Functional Magnetic Resonance Imaging
November 2, 2017 – 0740 – Pralatrexate (Folotyn)
November 2, 2017 – 0745 – Bell’s Palsy
November 2, 2017 – 0747 – Transanal Endoscopic Microsurgery
November 2, 2017 – 0748 – Panitumumab (Vectibix)
November 2, 2017 – 0749 – Anterior Segment Scanning Computerized Ophthalmic Diagnostic Imaging
November 2, 2017 – 0751 – Natalizumab (Tysabri)

Click here to view the Aetna Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!

Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.

Aetna